We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

33 hedge funds and large institutions have $30.6M invested in Cumberland Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 7

10% more funds holding

Funds holding: 30 → 33 (+3)

0.25% more ownership

Funds ownership: 34.15% → 34.41% (+0.25%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less capital invested

Capital invested by funds: $32.9M → $30.6M (-$2.3M)

Holders
33
Holders Change
+3
Holders Change %
+10%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
12
Reduced
7
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$88.7K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$33.4K
3
Renaissance Technologies
Renaissance Technologies
New York
+$25.1K
4
JP Morgan Chase
JP Morgan Chase
New York
+$22.8K
5
Northern Trust
Northern Trust
Illinois
+$16.5K

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$86.8K
2
BlackRock
BlackRock
New York
-$83K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$63.3K
4
Deutsche Bank
Deutsche Bank
Germany
-$30.9K
5
SEI Investments
SEI Investments
Pennsylvania
-$16.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
Ariel Investments
Illinois
$7.37M -$86.8K -14,735 -1%
SCM
2
Stonepine Capital Management
Oregon
$6.96M +$88.7K +15,062 +1%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$5.01M +$33.4K +5,674 +0.7%
Renaissance Technologies
4
Renaissance Technologies
New York
$2.18M +$25.1K +4,262 +1%
BlackRock
5
BlackRock
New York
$1.8M -$83K -14,086 -4%
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.79M – – –
New York State Common Retirement Fund
7
New York State Common Retirement Fund
New York
$1.49M – – –
BCM
8
Bridgeway Capital Management
Texas
$1.17M – – –
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$559K -$63.3K -10,753 -10%
BA
10
Bard Associates
Illinois
$452K -$2.95K -500 -0.6%
California Public Employees Retirement System
11
California Public Employees Retirement System
California
$307K – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$277K – – –
Prudential Financial
13
Prudential Financial
New Jersey
$170K +$589 +100 +0.3%
Northern Trust
14
Northern Trust
Illinois
$156K +$16.5K +2,798 +11%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$116K – – –
Morgan Stanley
16
Morgan Stanley
New York
$111K +$1.66K +281 +1%
Deutsche Bank
17
Deutsche Bank
Germany
$105K -$30.9K -5,238 -22%
UCFA
18
United Capital Financial Advisors
Texas
$95K – – –
State Street
19
State Street
Massachusetts
$81K +$3.26K +554 +4%
DAM
20
Delta Asset Management
Tennessee
$68K +$5.89K +1,000 +9%
SIM
21
Spark Investment Management
New York
$61K – – –
Cambridge Investment Research Advisors
22
Cambridge Investment Research Advisors
Iowa
$57K – – –
Macquarie Group
23
Macquarie Group
Australia
$33K +$9.53K +1,618 +39%
BA
24
Ballew Advisors
Mississippi
$31K -$253 -43 -0.8%
Russell Investments Group
25
Russell Investments Group
United Kingdom
$30K – – –
1
2

CPIX Hedge Fund Activity: Q3 2018 in Review

33 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q3 2018, worth a combined $30.6M — down 7% from $32.9M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CPIX positions and 0 closed out — a net gain of 3 holders — while 12 added to existing stakes and 7 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $88.7K. The largest seller was Ariel Investments, cutting an estimated $86.8K.

  • 33 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q3 2018, up from 30 in Q2 2018.
  • Funds reported $30.6M of Cumberland Pharmaceuticals stock for Q3 2018, down 7% quarter-over-quarter.
  • 3 funds opened new Cumberland Pharmaceuticals positions in Q3 2018 and 0 closed out, a net change of +3 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q3 2018 was Stonepine Capital Management, an estimated $88.7K added.
  • The largest Cumberland Pharmaceuticals seller in Q3 2018 was Ariel Investments, an estimated $86.8K sold.

Based on aggregated 13F filings for Q3 2018.